IL1B and Behcet disease: From our previous control experiments, we observed that when administering IL-1β in the recipient post-LT, an increase in IL-1β levels in the plasma from recipients of groups BD+IL-6+IL-1+LT and BD+IL-10+IL-1+LT was registered at 4 h of reperfusion (data not shown).